Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Metabolomic in Critical Ill Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2016 by Università Vita-Salute San Raffaele
Information provided by (Responsible Party):
Giovanni Landoni, Università Vita-Salute San Raffaele Identifier:
First received: January 9, 2012
Last updated: March 9, 2016
Last verified: March 2016
Analysis of blood, urinary, and intrathecal metabolites of critical ill patients will be checked for possible correlations between metabolomics patterns and patients' outcomes.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Further study details as provided by Università Vita-Salute San Raffaele:

Primary Outcome Measures:
  • Metabolomic patterns to identify poor outcome [ Time Frame: hospital stay (approximately two weeks) ] [ Designated as safety issue: No ]

Study Start Date: January 2015
Estimated Study Completion Date: December 2016
Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
criticall ill patients


Ages Eligible for Study:   18 Years to 99 Years   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Critical ill patients

Inclusion Criteria:

  • patients with severe left or right ventricular dysfunction undergoing cardiac surgery
  • patients undergoing ablation of ventricular tachycardia
  • patients with febrile neutropenia after chemotherapy or allogeneic transplant for haematological diseases
  • patients undergoing thoracoabdominal vascular surgery

Exclusion Criteria:

  • pregnant women
  • no written consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01506674

Università Vita-Salute San Raffaele Recruiting
Milano, Mi, Italy, 20132
Contact: Giovanni Landoni   
Contact: Laura Pasin   
Sponsors and Collaborators
Università Vita-Salute San Raffaele
  More Information

Responsible Party: Giovanni Landoni, MD, Associate Professor, Università Vita-Salute San Raffaele Identifier: NCT01506674     History of Changes
Other Study ID Numbers: HSR CEmet 
Study First Received: January 9, 2012
Last Updated: March 9, 2016
Health Authority: Italy: Ministry of Health processed this record on October 21, 2016